^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

EGF expression

i
Other names: EGF, Epidermal Growth Factor, HOMG4, Beta-Urogastrone
Entrez ID:
Related biomarkers:
1m
NRF2 regulates EGF stability through OTUD4 in lung adenocarcinoma. (PubMed, Biochem Biophys Res Commun)
More importantly, OTUD4 and NRF2 expression was found being correlated in LUAD patients. The data collectively revealed a novel mechanism of NRF2 regulating on EGF stability through OTUD4 in LUAD.
Journal
|
NFE2L2 (Nuclear Factor, Erythroid 2 Like 2) • EGF (Epidermal growth factor)
|
EGF expression
6ms
Effects and mechanism of astragalus polysaccharide on wound healing of deep partial-thickness burns in rats (PubMed, Zhonghua Shao Shang Za Zhi)
There were no statistically significant differences in the protein expressions of Akt and GSK-3β in normal skin tissue of rats in normal group and wound tissue of rats with burns in the four groups (P>0.05). APS can alleviate systemic and local inflammation, alleviate tissue edema, and promote the expressions of healing factors in rats with deep partial-thickness burns, thus to promote the wound healing, possibly by activating ILK/Akt/GSK-3β signaling pathway.
Preclinical • Journal
|
IFNG (Interferon, gamma) • TNFA (Tumor Necrosis Factor-Alpha) • IL2 (Interleukin 2) • EGF (Epidermal growth factor) • ILK (Integrin Linked Kinase)
|
EGF expression
12ms
Her2 positive as the main biomarker for overall survival of advanced gastric adenocarcinoma: Latin American reality and challenges (ESMO-GI 2023)
HER2 overexpression along the grade differentiation has remained an independent predictor of OS, and the number of patients treated with trastuzumab is low compared with other countries. The use of molecular-targeted treatments in HER2-positive gastric cancer is fundamental to improving OS. Nevertheless, despite several progress in prolonging these patients' OS, access to molecular treatments remains a challenge for Latin America.
Clinical • Metastases
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 positive • HER-2 overexpression • HER-2 negative • EGF expression
|
Herceptin (trastuzumab)
1year
Expression of CD24 gene in human malignant pleural mesothelioma and its relationship with prognosis (PubMed, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi)
Compared with low expression of CD24 gene, high expression of CD24 gene was an independent risk factor for the prognosis of MPM patients (HR=2.412, 95%CI: 1.291-4.492, P=0.006) . CD24 gene and protein are highly expressed in MPM tissues, and the high expression of CD24 gene suggests poor prognosis in MPM patients.
Journal
|
TP53 (Tumor protein P53) • MSLN (Mesothelin) • CD24 (CD24 Molecule) • EGF (Epidermal growth factor) • CALB1 (Calbindin 1) • THBS2 (Thrombospondin 2) • CALB2 (Calbindin 2) • EFEMP1 (EGF Containing Fibulin Extracellular Matrix Protein 1)
|
TP53 mutation • TP53 expression • CD24 overexpression • CD24 expression • EGF expression
over1year
Histone Methyltransferase KMT2B Promotes Metastasis and Angiogenesis of Cervical Cancer by Upregulating EGF Expression. (PubMed, Int J Biol Sci)
Moreover, EGFR inhibitors abolished the KMT2B-drived tube formation capacity of HUVECs. In conclusion, KMT2B facilitates CC metastasis and angiogenesis by upregulating EGF expression, and may serve as a new therapeutic target for CC.
Journal • Epigenetic controller
|
EGF (Epidermal growth factor)
|
EGF expression
over1year
Clinical Utility of Mifepristone: Apprising the Expanding Horizons. (PubMed, Cureus)
Mifepristone is a progesterone and glucocorticoid receptor antagonist. Apoptotic action of mifepristone, interference of heterotypic cell adhesion to the basement membrane, cell migration, growth inhibition of various cancer cell lines, decreased epidermal growth factor expression, suppression of invasive and metastatic cancer potential, increase in tumor necrosis factor, downregulation of cyclin-dependent kinase 2, B-cell lymphoma 2, and Nuclear factor kappa B have opened its potential to be explored as anti-cancer treatment and its effects on leiomyoma. The drug needs to be studied more for the prospectus of its anti-glucocorticoid actions in a wider dimension beyond its acquiescence for the treatment of Cushing syndrome.
Review • Journal
|
BCL2 (B-cell CLL/lymphoma 2) • TNFA (Tumor Necrosis Factor-Alpha) • CDK2 (Cyclin-dependent kinase 2) • EGF (Epidermal growth factor)
|
EGF expression
|
Mifeprex (mifepristone)
almost2years
METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/Rad51 axis. (PubMed, Elife)
Knockdown of METTL3 sensitized these BC cells to Adriamycin (ADR; also named as doxorubicin) treatment and increased accumulation of DNA damage...We further demonstrated that the m6A 'reader', YTHDC1, bound to the m6A modified EGF transcript and promoted EGF synthesis, which enhanced HR and cell survival during ADR treatment in breast cancer cells. Our findings reveal a pivotal mechanism of METTL3-mediated HR and chemotherapeutic drug response, which may contribute to cancer therapy.
Journal
|
HRD (Homologous Recombination Deficiency) • RAD51 (RAD51 Homolog A) • METTL3 (Methyltransferase Like 3)
|
EGF expression
|
doxorubicin hydrochloride
2years
Revealing therapeutic targets and mechanism of baicalin for anti-chronic gastritis using proteomic analysis of the gastric tissue. (PubMed, J Chromatogr B Analyt Technol Biomed Life Sci)
We investigated the effects and potential mechanism of BCL in chronic gastritis. Proteomic technology was used to explore BCL-affected proteins and some signalling pathways. The results may provide important insights into discovering potential target proteins for treating chronic gastritis.
Journal
|
BCL2 (B-cell CLL/lymphoma 2) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • ICAM1 (Intercellular adhesion molecule 1) • EGF (Epidermal growth factor) • TPM2 (Tropomyosin 2)
|
BCL2 expression • EGF expression
|
omeprazole
over2years
CRISPR/Cas9 and Transgene Verification of Gene Involvement in Unfolded Protein Response and Recombinant Protein Production in Barley Grain. (PubMed, Front Plant Sci)
The overexpression of IPI in a F cross showed a significant increase in EGF expression. We demonstrate that manipulation of UPR related genes can have a positive effect on recombinant protein accumulation.
Journal
|
HER-2 (Human epidermal growth factor receptor 2) • EGF (Epidermal growth factor) • CALR (Calreticulin)
|
EGF expression
over2years
mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab. (PubMed, Oncol Lett)
In patients with de novo MBC, high EGF expression was associated with a non-significant prolongation of TTP (HR=0.52, P=0.080) and significantly longer survival (HR=0.40, P=0.020). The present study examined clinical and biological implications of specific genes and it was concluded that their expression has an impact on the outcome of trastuzumab-treated patients with MBC.
Clinical • Clinical data • Journal
|
HER-2 (Human epidermal growth factor receptor 2) • NRG1 (Neuregulin 1) • TGFB1 (Transforming Growth Factor Beta 1)
|
HER-2 positive • HER-2 expression • EGF expression
|
Herceptin (trastuzumab) • trastuzumab biosimilar
over2years
NAAA is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth. (PubMed, Br J Pharmacol)
Our results provide unprecedented data on the functional importance of NAAA in CRC progression and its mechanism. We propose this enzyme as a valid drug target for the treatment of CRC growth and development.
Clinical • Journal
|
CCNA2 (Cyclin A2) • CDK2 (Cyclin-dependent kinase 2) • EGF (Epidermal growth factor)
|
EGF expression
almost3years
Traditional Chinese medicine Bu-Shen-Jian-Pi-Fang attenuates glycolysis and immune escape in clear cell renal cell carcinoma: results based on network pharmacology. (PubMed, Biosci Rep)
In summary, this study demonstrated that the mechanism of BSJPF involves multiple targets and signaling pathways related to tumorigenesis and glycolysis metabolism in ccRCC. Our research provides a novel theoretical basis for the treatment of tumors with traditional Chinese medicine and new strategies for immunotherapy in ccRCC patients.
Journal • PD(L)-1 Biomarker • IO biomarker
|
PD-L1 (Programmed death ligand 1) • LDHA (Lactate dehydrogenase A) • HIF1A (Hypoxia inducible factor 1, alpha subunit)
|
VEGFA expression • EGF expression
3years
Bioinformatics and Functional Analyses Implicate Potential Roles for EOGT and L-fringe in Pancreatic Cancers. (PubMed, Molecules)
EOGT expression is significantly increased in the basal subtype, and low expression of both EOGT and LFNG predicts better overall survival in PDAC patients. These results imply potential roles for EOGT- and LFNG-dependent Notch signaling in PDAC.
Journal
|
EGF (Epidermal growth factor)
|
EGF expression
3years
Epidermal growth factor upregulates the expression of A20 in hepatic cells via the MEK1/MSK1/p-p65 (Ser276) signaling pathway. (PubMed, Am J Transl Res)
The EGF-induced A20 upregulation was NF-κB-dependent and abolished by either the overexpression of the nuclear factor of a κ light polypeptide gene enhancer in a B-cell inhibitor α or treatment with the NF-κB inhibitor BAY11-7082...To our knowledge, the present study is the first to demonstrate that EGF induced A20 expression by activating the MEK1/MSK1/p-p65 (Ser276) signaling pathway without causing an apparent inflammatory response. These results may further extend our understanding of liver inflammation and tumor development.
Journal
|
MAP2K1 (Mitogen-activated protein kinase kinase 1) • TNFA (Tumor Necrosis Factor-Alpha) • TNFAIP3 (TNF Alpha Induced Protein 3) • ICAM1 (Intercellular adhesion molecule 1) • CCL2 (Chemokine (C-C motif) ligand 2) • EGF (Epidermal growth factor) • VCAM1 (Vascular Cell Adhesion Molecule 1)
|
EGF expression
|
Bay11-7082
over3years
Overexpression of LINC00691 promotes the proliferation and invasion of gastric cancer cells via the Janus kinase/signal transducer and activator of transcription signalling pathway. (PubMed, Int J Biochem Cell Biol)
The Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway inhibitor ruxolitinib effectively suppressed the effects of LINC00691...Therefore, our study clarified that LINC00691 is highly expressed in GC and is a potential biomarker for GC diagnosis and prognosis. LINC00691 promotes the proliferation and invasion of GC cells by activating Lin28 transcription and facilitating EGF expression through the JAK/STAT signalling pathway, which provides new ideas for targeted therapy of GC.
Journal
|
JAK2 (Janus kinase 2) • STAT3 (Signal Transducer And Activator Of Transcription 3) • EGF (Epidermal growth factor)
|
EGF expression
|
Jakafi (ruxolitinib)
over3years
Expression of miR-1304 in patients with esophageal carcinoma and risk factors for recurrence. (PubMed, World J Gastroenterol)
miR-1304 can be used as a potential indicator for the diagnosis and recurrence of esophageal carcinoma and for survival of patients with this disease.
Clinical • Journal
|
EGF (Epidermal growth factor)
|
EGF expression
over3years
Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer-insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system. (PubMed, Breast Cancer Res)
Our data suggest that despite an increase in ITGA2 and ITGB1 gene expression in the EMT exhibited by EDW01 PDX over multiple generations, this pathway may not necessarily drive the EMT process.
Journal
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • CTNNB1 (Catenin (cadherin-associated protein), beta 1) • CDH1 (Cadherin 1) • CD44 (CD44 Molecule) • CA9 (Carbonic anhydrase 9) • CD24 (CD24 Molecule) • VIM (Vimentin)
|
CDH1 expression • CDH1 mutation • VIM expression • EGF expression
over3years
The HIF1α/HIF2α-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions. (PubMed, Cell Death Dis)
Therefore, we focused on the reason and found that treatments targeting HIF1α and HIF2α simultaneously increased tumour volume, but the combination of HIF1α/HIF2α-targeted therapies with temozolomide (TMZ) reduced tumourigenesis and significantly improved chemosensitization...Additionally, differentiated glioblastoma cells underwent dedifferentiation to produce glioma stem cells under hypoxic conditions, and simultaneous knockout of HIF1α and HIF2α inhibited cell cycle arrest but promoted proliferation with decreased stemness, promoting glioblastoma cell chemosensitization. In summary, both HIF1α and HIF2α regulate glioblastoma cell proliferation, dedifferentiation and chemoresistance through a specific pathway, which is important for glioblastoma treatments.
Journal
|
HIF1A (Hypoxia inducible factor 1, alpha subunit) • EGF (Epidermal growth factor)
|
HIF1A expression • EGF expression
|
temozolomide
over3years
[VIRTUAL] Epidermal growth factor modulation of CXCL10 in keratinocytes and cutaneous cancers (SITC 2020)
Moreover, these studies suggest that in the setting of high EGF levels, there is a modulation of IFN-g-regulated chemokine expression. Further research is needed to clarify the role of EGF in modulating inflammation, and to understand this process in the pathogenesis of EGF receptor inhibitor-induced cutaneous toxicities and skin cancers.
IO biomarker
|
CD74 (CD74 Molecule) • IFNG (Interferon, gamma) • CXCL10 (Chemokine (C-X-C motif) ligand 10) • IDO1 (Indoleamine 2,3-dioxygenase 1)
|
HER-2 expression • IFNG expression • EGF expression
over3years
[VIRTUAL] Epidermal growth factor modulation of CXCL10 in keratinocytes and cutaneous cancers (SITC 2020)
Moreover, these studies suggest that in the setting of high EGF levels, there is a modulation of IFN-g-regulated chemokine expression. Further research is needed to clarify the role of EGF in modulating inflammation, and to understand this process in the pathogenesis of EGF receptor inhibitor-induced cutaneous toxicities and skin cancers.
IO biomarker
|
CD74 (CD74 Molecule) • IFNG (Interferon, gamma) • CXCL10 (Chemokine (C-X-C motif) ligand 10) • IDO1 (Indoleamine 2,3-dioxygenase 1)
|
HER-2 expression • IFNG expression • EGF expression
over3years
Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients. (PubMed, Asian Pac J Cancer Prev)
EGF gene polymorphism (GG genotype) had a significant risk of HCC development in cirrhotic patients. This is confirmed by increased EGF expression in liver tumor tissue from HCC patients.
Clinical • Journal
|
EGF (Epidermal growth factor)
|
EGF expression
4years
HB-EGF Synthesized by CD4 T Cells Modulates Allergic Airway Eosinophilia by Regulating IL-5 Synthesis. (PubMed, J Immunol)
Knocking out HB-EGF in CD4 T cells resulted in increased Bcl-6 binding to the IL-5 gene and decreased IL-5 mRNA expression. Thus, these findings suggest an immunoregulatory function for intrinsic HB-EGF expressed by CD4 T cells in T2 inflammation and airway dysfunction by modulating IL-5 expression via binding to and inhibiting the repressive function of Bcl-6.
Journal
|
BCL6 (B-cell CLL/lymphoma 6) • EGF (Epidermal growth factor)
|
EGF expression